Management of benign prostatic hyperplasia

被引:24
作者
Barry, M [1 ]
Roehrborn, C [1 ]
机构
[1] UNIV TEXAS, SW MED CTR, DEPT SURG, DIV UROL, DALLAS, TX 75235 USA
来源
ANNUAL REVIEW OF MEDICINE | 1997年 / 48卷
关键词
adrenergic alpha-antagonists; finasteride; prostatectomy; prostate-specific antigen; prostatic hyperplasia;
D O I
10.1146/annurev.med.48.1.177
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Benign prostatic hyperplasia (BPH) is a common cause of morbidity among older men. Primary care physicians need to develop expertise in its management. The causes of BPH are unknown; aging and the presence of male androgens are the dominant risk factors. Obtaining a medical history is a key step in assessing whether lower urinary tract symptoms are due to BPH or to some other process. A reliable and valid seven-item questionnaire has been developed to objectively assess symptom severity. A focused physical examination including a digital rectal exam should be performed, as well as a urinalysis and serum creatinine. Optional tests include uroflowmetry, post-void residual urine, and prostate-specific antigen measurements. BPH is treated primarily to improve the quality, rather than increase the quantity, of life. Optimal decisions about treatment are best made by a clinician and an informed patient working together.
引用
收藏
页码:177 / 189
页数:13
相关论文
共 40 条
[1]   NEW WORDS FOR OLD - LOWER URINARY-TRACT SYMPTOMS FOR PROSTATISM [J].
ABRAMS, P .
BRITISH MEDICAL JOURNAL, 1994, 308 (6934) :929-930
[2]   IN SUPPORT OF PRESSURE-FLOW STUDIES FOR EVALUATING MEN WITH LOWER URINARY-TRACT SYMPTOMS [J].
ABRAMS, P .
UROLOGY, 1994, 44 (02) :153-155
[3]   A MULTICENTER, RANDOMIZED, PROSPECTIVE-STUDY OF ENDOSCOPIC LASER-ABLATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE [J].
ANSON, K ;
NAWROCKI, J ;
BUCKLEY, J ;
FOWLER, C ;
KIRBY, R ;
LAWRENCE, W ;
PATERSON, P ;
WATSON, G .
UROLOGY, 1995, 46 (03) :305-310
[4]   THE NATURAL-HISTORY OF UNTREATED PROSTATISM [J].
BALL, AJ ;
FENELEY, RCL ;
ABRAMS, PH .
BRITISH JOURNAL OF UROLOGY, 1981, 53 (06) :613-616
[5]   RELATIONSHIP OF SYMPTOMS OF PROSTATISM TO COMMONLY USED PHYSIOLOGICAL AND ANATOMICAL MEASURES OF THE SEVERITY OF BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
COCKETT, ATK ;
HOLTGREWE, HL ;
MCCONNELL, JD ;
SIHELNIK, SA ;
WINFIELD, HN .
JOURNAL OF UROLOGY, 1993, 150 (02) :351-358
[6]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[7]  
BARRY MJ, 1996, IN PRESS AM UROL ASS
[8]   THE USE OF PROSTATE SPECIFIC ANTIGEN DENSITY TO ENHANCE THE PREDICTIVE VALUE OF INTERMEDIATE LEVELS OF SERUM PROSTATE SPECIFIC ANTIGEN [J].
BENSON, MC ;
WHANG, IS ;
OLSSON, CA ;
MCMAHON, DJ ;
COONER, WH .
JOURNAL OF UROLOGY, 1992, 147 (03) :817-821
[9]  
Boyle P., 1996, Journal of Urology, V155, p572A
[10]   VALUE OF POSTVOID RESIDUAL URINE DETERMINATION IN EVALUATION OF PROSTATISM [J].
BRUSKEWITZ, RC ;
IVERSEN, P ;
MADSEN, PO .
UROLOGY, 1982, 20 (06) :602-604